Document is current
Any future updates will be listed below
-
Authors
Lünemann, Jan D. https://orcid.org/0000-0002-3007-708X
- License Information
-
More Information
Article History
First Online: 23 August 2021
Competing interests
: J.D.L. has received speaker fees, research support, and/or served on advisory boards at the Swiss National Science Foundation, the German Research Foundation, the Swiss Multiple Sclerosis Society, AbbVie, Alexion, ArgenX, Bayer AG, Biogen Inc, F. Hoffmann-La Roche, Merck & Co., Novartis AG and Sanofi Genzyme.
